J2150 NDC Crosswalk, Billing Units, ASP Payment & Medicare Reimbursement

📋 J2150 summary

J2150 is a HCPCS Level II J-code used to bill mannitol, 25% in 50 ml. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J2150: Mannitol(J2150)

Code J2150 NDC-Crosswalk 3 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ2150

DescriptorInjection, mannitol, 25% in 50 ml

Billing unitNot available in current dataset

Payment limit / unit Not available in current dataset

Mapped NDCs3

Data periodNot available in current dataset

Last updatedSource date not available

🧾 Billing & reimbursement HCPCS · CMS

Medicare payment limit / unit

—

Est. ASP / unit

—

Est. after 2% sequester

—

HCPCS dosage

—

The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).

Full HCPCS code details (official CMS record)

Long descriptionInjection, mannitol, 25% in 50 ml

CoverageD — Special coverage instructions apply

Pricing indicator51 — Drug — priced under the ASP methodology

Type of service1 — Medical care

BETOS-2O1E

ASC payment group—

Action codeN — No maintenance this year

Effective date1997-01-01

Date added1986-01-01

Source: CMS HCPCS Level II code file (imported via admin).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J2150 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.

Dose per administration (unit) Frequency — every days Number of doses NDC / package billed (optional)

Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J2150 CROSSWALKED NDCs

3 NDCs map to J2150. Bill units = how many HCPCS units one package represents.

NDC (11-digit)	Drug	Labeler	Package	Strength	Bill units	NADAC / unit	Status	Source
00990-7715-02	Mannitol 20 g/100mL INJECTION, SOLUTION	ICU	24 POUCH in 1 CASE (0990-7715-02) / 1 BAG...	20 g/100mL	0.016	—	● Active	PDAC
00409-4031-01	Mannitol 12.5 g/50mL INJECTION, SOLUTION	Hospira,	25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4031-...	12.5 g/50mL	0.02	—	● Active	PDAC
63323-0024-25	Mannitol 250 mg/mL INJECTION, SOLUTION	Fresenius	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-024-...	250 mg/mL	0.02	—	● Active	PDAC

NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

⚠️ Don't confuse J2150 with… RELATED CODES

Adjacent HCPCS codes that share an ingredient or formulation with J2150. Billing units and payment limits differ — confirm the exact code, strength and form before billing.

Code	Descriptor	Billing unit	Payment limit / unit	How it differs from J2150
J2151	MANNITOL	250 MG	$0.071	Related ingredient or formulation — confirm strength, form and billing unit before substituting.

Related codes matched on shared ingredient (CMS Medicare Part B Spending feed). Billing units and payment limits from the CMS ASP Pricing File. Always verify the precise HCPCS code for the product and strength administered.

📊 Medicare utilization & spend CMS · PART B · 2025 (Q1-Q4)

Total Part B spend

$9.3K

Claims

3,129

Beneficiaries

682

Spend / beneficiary

$13.68

Spend / claim

$2.98

Where J2150 ranks among Part B drugs · 2025 (Q1-Q4) · neighbors ±5

Total spending — #807 of 918

#802 ATIVAN* J2060 $10.2K #803 CLEOCIN PHOSPHATE* J0736 $10K #804 AMPHADASE J3470 $9.8K #805 HYPERRHO* J2790 $9.6K #806 COMBOGESIC IV J0138 $9.4K #807 MANNITOL(J2150) J2150 $9.3K #808 INTEGRA MATRIX** Q4108 $9.2K #809 IMMPHENTIV J2373 $9K #810 CEFAZOLIN SODIUM(J06... J0687 $9K #811 DOXY 100* J1271 $8.6K #812 RECARBRIO J0742 $8.5K

Total claims — #435 of 918

#430 GAMMAPLEX J1557 3,238 #431 CUTAQUIG J1551 3,236 #432 HALDOL DECANOATE 100... J1631 3,227 #433 ENJAYMO J1302 3,189 #434 ENGERIX-B ADULT(9074... 90740 3,142 #435 MANNITOL(J2150) J2150 3,129 #436 ISTODAX* J9319 3,095 #437 METOCLOPRAMIDE HCL J2765 3,076 #438 EPOPROSTENOL SODIUM* J1325 3,067 #439 KINEVAC* J2805 3,039 #440 DURAMORPH* J2274 2,956

Full breakdown by period (1)

Period	Total spend	Beneficiaries	Claims	$/beneficiary	$/claim
2025 (Q1-Q4)	$9.3K	682	3,129	$13.68	$2.98

Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.

Allowed charges

$8.7K

Medicare paid

$7.3K

Submitted services

5,125

Denial rate

25.6%

Allowed / service

$2.28

Submitted charges

$65.3K

Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J2150 is utilized CMS · BY PROVIDER · 2024

Medicare Part B services for this code by the rendering provider's state — 527 services across 6 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.

Hover or tap a state to see its numbers + top ZIP codes.

Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.

📊 What bills under J2150

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient

MANNITOL 3

NDC products by labeler

Hospira, Inc. 1

ICU Medical Inc. 1

Fresenius Kabi USA, LLC 1

🔗 Related NDC directory pages

🧪 All Mannitol NDCsIngredient 🏭 All Hospira, labeler NDCsLabeler 00409 🏭 All ICU labeler NDCsLabeler 00990 🏭 All Fresenius labeler NDCsLabeler 63323 📚 All Osmotic Diuretic NDCsDrug class

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.

HCPCS code & descriptor

CMS HCPCS Level II code file

Loaded

Payment limit & billing unit

CMS Medicare Part B ASP Pricing File (quarterly)

Not available

NDC ↔ HCPCS crosswalk

CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)

3 NDCs mapped

NADAC acquisition cost

CMS National Average Drug Acquisition Cost (weekly)

Not available for mapped NDCs

Utilization & spend

CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners

Latest data year 2025

Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J2150 billing FAQ

What is HCPCS code J2150?

J2150 is a HCPCS Level II J-code used to bill Injection, mannitol, 25% in 50 ml under Medicare Part B and most medical (not pharmacy) benefits.

Which NDCs bill under J2150?

3 NDCs currently map to J2150 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.

Does a crosswalk mean J2150 is covered?

No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.

J2150 – Injection, mannitol, 25% in 50 ml · NDC Crosswalk & Billing Units